Nirsevimab effectiveness against hospital admission for respiratory syncytial virus bronchiolitis in infants
The implementation of nirsevimab has had an important impact on the number of hospital admissions for RSV bronchiolitis. There were no differences in the severity of bronchiolitis.
Authors
- Jesús Pérez‐Moreno (ORCID: https://orcid.org/0000-0001-5216-8313)
- Rosa Rodríguez Fernández (ORCID: https://orcid.org/0000-0001-6985-8118)
- Francisco González-Martínez
- María-Isabel González-Sánchez (ORCID: https://orcid.org/0000-0002-7390-5420)
- M Rodríguez Díaz
- M V Capozzi Bucciol
- B. Toledo del Castillo
- Inés Ojeda Velázquez (ORCID: https://orcid.org/0000-0002-1065-3369)
Institutions
- Hospital Fernández (AR)
Publication Details
- Journal
- Revista Española de Quimioterapia
- Published
- 2024-09-23
- DOI
- https://doi.org/10.37201/req/026.2024
- Citations
- 5
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 1.93